Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHPCX vs. RYOIX: which is better?

Bottom line

SHPCX vs RYOIX: the short answer

SHPCX (Health & Biotechnology Portfolio) and RYOIX (Biotechnology Fund) are both mutual funds.

But RYOIX is far broader, holding 74 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.

RYOIX is cheaper at 1.38% vs 3.6% — a difference of $222 a year per $10,000 invested.

Over five years, RYOIX returned +4.0% a year vs +3.7% for SHPCX (reporting dates differ).

Updated Nov 19, 2026

SHPCX vs RYOIX side by side

SHPCXRYOIX
TypeMutual fundMutual fund
Fund familySaratoga AdvantageGuggenheim
CategoryTechnology SectorTechnology Sector
Expense ratio3.6%1.38%
Annual cost per $10k$360$138
10-yr cost on $10k (prospectus)$3,862$1,709
Max front load0%—
12b-1 fee—0%
1-yr return−1.3%+30.7%
5-yr return (annualized)+3.7%+4.0%
10-yr return (annualized)+4.1%+5.9%
Best quarter+15.0%+28.3%
Worst quarter−13.0%−22.5%
Net assets (fund)$10.5M$136.8M
Number of holdings2974
Portfolio turnover22%75%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHPCXRYOIXDifference
2024−0.3%−0.7%+0.4%
2023−0.9%+6.1%−7.0%
2022+1.4%−13.1%+14.5%
2021+16.0%+1.8%+14.2%
2020+3.0%+22.1%−19.1%
2019+15.4%+25.0%−9.6%
2018−6.0%−9.0%+3.0%
2017+11.3%+29.7%−18.5%
2016−2.5%−19.5%+17.0%

Source: Fund prospectus bar charts

Holdings overlap

6 of SHPCX's top 25 holdings also appear in RYOIX's top 25.

Shared top holdings
HoldingSHPCXRYOIX
United Therapeutics Corp6.17%1.72%
Amgen Inc5.04%5.05%
Gilead Sciences Inc3.94%4.49%
Regeneron Pharmaceuticals Inc3.93%2.93%
Vertex Pharmaceuticals Inc3.36%4.32%
Incyte Corp2.89%1.62%

Source: SEC Form N-PORT

SHPCX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FAQ

What is the difference between SHPCX and RYOIX?
SHPCX (Health & Biotechnology Portfolio) and RYOIX (Biotechnology Fund) are both mutual funds. But RYOIX is far broader, holding 74 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.
Which is cheaper, SHPCX or RYOIX?
RYOIX has the lower expense ratio (1.38%).
Should I own both SHPCX and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.